High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes

Table 1 Clinical and Biological Characteristic of CHD Patients with Diabetes and CHD Patients without Diabetes

	CHD Patients with Diabetes (n = 115)	CHD Patients without Diabetes (n = 97)
Age(yr)	67.1 ± 9.7	63.7 ± 8.3
Female/Male	45/70	53/44
SBP(mmHg)	135.2 ± 20.6	130.8 ± 17.7
DBP(mmHg)	77.6 ± 8.4	75.7 ± 7.5
BMI(kg/m ² )	25.0 ± 2.6	24.3 ± 2.1
Waist (cm)	92.4 ± 8.6	88.1 ± 7.8^†
Hip (cm)	94.2 ± 6.4	93.1 ± 5.7
WHR	0.98 ± 0.1	0.94 ± 0.1^†
Gensini Score	53.7 ± 9.2	22.9 ± 6.3^†
FPG(mmol/L)	9.0 ± 1.2	5.2 ± 0.6^‡
TG(mmol/L)	2.2 ± 0.5	1.8 ± 0.6^*
TC(mmol/L)	4.4 ± 1.1	3.9 ± 1.0^*
LDL-C(mmol/L)	3.4 ± 1.0	2.7 ± 0.7^†
HDL-C(mmol/L)	1.0 ± 0.2	1.3 ± 0.2^†
ApoA-I(g/L)	1.1 ± 0.2	1.3 ± 0.3^*
ApoB-100(g/L)	0.8 ± 0.2	0.6 ± 0.2^*
ApoB-100/A-I	0.7 ± 0.2	0.5 ± 0.1^*
Preβ ₁ -HDL(mg/L)	92.0 ± 9.5	83.0 ± 7.0
HDL _3c (mg/L)	83.9 ± 7.4	78.5 ± 6.9
HDL _3b (mg/L)	170.2 ± 20.9	142.5 ± 18.2^*
HDL _3a (mg/L)	310.5 ± 44.7	272.5 ± 38.1^*
HDL _2a (mg/L)	190.5 ± 25.8	285.9 ± 42.2^‡
HDL _{2b+Preβ2-HDL} (mg/L)	311.9 ± 52.2	389.3 ± 69.5^‡

CHD, coronary heart disease; BMI, body mass index; FPG, fasting plasma glucose; TG, triglyceride; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; ApoA-I, apolipoproteinA-I; ApoB-100, apolipoprotein B-100.
Data are presented as Mean ± S.D.
^*P < 0.05, ^†P < 0.01, ^‡P < 0.001 vs CHD with diabetic patients.

ISSN: 1476-511X